Centocor Remicade RA Launch Will Get J&J Support, Ultram Experience
Executive Summary
Centocor will have the support and experience of J&J's pain product marketing for the expansion of Remicade into the rheumatoid arthritis market.
You may also be interested in...
J&J Buys Scios: Will Natrecor Make Another Centocor?
Johnson & Johnson will gain access to Scios' Phase II oral rheumatoid arthritis program through its proposed $2.4 bil. acquisition of the biotech company
J&J Buys Scios: Will Natrecor Make Another Centocor?
Johnson & Johnson will gain access to Scios' Phase II oral rheumatoid arthritis program through its proposed $2.4 bil. acquisition of the biotech company
J&J Adds New Dimension To Drug Discovery Efforts With 3DP Acquisition
Johnson & Johnson's purchase of 3-Dimensional Pharmaceuticals has more of a research focus than its other recent drug acquisitions